How do you pay?

How to pay the least

Cash price

$1,310+ for 30 tablets

Pharmacies pay about this for Orilissa; you’d pay more.

  1. Ask your pharmacy for Orilissa’s cash price, and one or two other pharmacies too.
  2. Orilissa’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameOrilissa
Authorized genericelagolix
Regular genericelagolix
What you’d pay
At least$1,310for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Orilissa?
The original
–
–

Brand nameThe maker’s card

ORILISSA Savings Card

Savings card from AbbVie

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $5 a month

The card takes up to $5,000 a year off your co-pay.

Sign up on orilissa.com 

Or call 1-800-674-5477.

In the maker’s words

“You may pay as little as $5 a month with the Orilissa Savings Card, if you have commercial insurance.”

From the maker’s offer on orilissa.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Orilissa itself, from the same company, sold without the brand name, and usually for less. For now Orilissa is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

ORILISSA is a gonadotropin-releasing hormone (GnRH) receptor antagonist indicated for the management of moderate to severe pain associated with endometriosis.

Limitation s of Use:

  • Limit the duration of use based on the dose and coexisting condition (see Table 1).

Source: the FDA label for Orilissa (AbbVie Inc.), December 19, 2025. Full label on DailyMed 

Good to know